Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Neurochem ; 73(1): 187-94, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10386970

RESUMEN

The possibility that the mechanism of lead neurotoxicity may be at the level of transcription was investigated in PC12 cells. In electrophoretic mobility gel shift assays Pb2+ was found to increase activator protein-1 complex (AP-1) DNA binding activity in PC12 cells; the increase was time- and concentration-dependent. Exposure to Pb2+ also resulted in an increase in AP-1-driven transcription in cerebellar granule cells transfected with a luciferase gene reporter construct. The increase in AP-1 DNA binding activity by Pb2+ required protein synthesis. The increase was mediated by protein kinase C because depletion of protein kinase C and an inhibitor of protein kinase C prevented the increase in AP-1 DNA binding activity by Pb2+. Fra-2 and JunD were found in supershift assays to be the major components of the AP-1 that was increased by Pb2+. In summary, our studies indicate that Pb2+ increases AP-1 DNA binding activity in PC12 cells by a pathway that requires protein kinase C and new protein synthesis.


Asunto(s)
ADN/metabolismo , Compuestos Organometálicos/farmacología , Células PC12/efectos de los fármacos , Células PC12/metabolismo , Factor de Transcripción AP-1/metabolismo , Animales , Cerebelo/metabolismo , Relación Dosis-Respuesta a Droga , Genes fos , Genes jun , Cinética , Compuestos Organometálicos/administración & dosificación , Forbol 12,13-Dibutirato/farmacología , Biosíntesis de Proteínas , Proteína Quinasa C/metabolismo , Inhibidores de la Síntesis de la Proteína/farmacología , Ratas , Factor de Transcripción AP-1/genética , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA